title: Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.
authors.forename: M A
authors.initials: MA
authors.lastname: van der Pol
authors.forename: N
authors.initials: N
authors.lastname: Feller
authors.forename: G J
authors.initials: GJ
authors.lastname: Ossenkoppele
authors.forename: G W D
authors.initials: GW
authors.lastname: Weijers
authors.forename: A H
authors.initials: AH
authors.lastname: Westra
authors.forename: A
authors.initials: A
authors.lastname: van Stijn
authors.forename: H J
authors.initials: HJ
authors.lastname: Broxterman
authors.forename: G J
authors.initials: GJ
authors.lastname: Schuurhuis
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000473:pathology; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000473:pathology; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000473:pathology; D011237:Predictive Value of Tests; D018709:Statistics, Nonparametric
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1